Literature DB >> 26531333

Combined Extraperitoneal and Transperitoneal Laparoscopic Extended Partial Cystectomy for the Treatment of Urachal Carcinoma.

Baojun Wang1, Xintao Li1, Shaoxiong Ming2, Xin Ma1, Hongzhao Li1, Qing Ai1, Xu Zhang1.   

Abstract

PURPOSE: To evaluate the application of laparoscopic extended partial cystectomy (PC) and bilateral extended pelvic lymph node dissection (PLND) for the treatment of urachal carcinomas (UrCs).
METHODS: Combined laparoscopic extended PC and bilateral extended PLND was performed in 16 cases with UrCs in our hospital between April 2009 and December 2012. The surgical procedure included the dilation of the extraperitoneal space, circumscription of the umbilicus, dissection from the umbilicus caudad to the dome of the bladder, excision of the tumor, and the suture of the bladder. The average age of the patients was 52.8 years (35-73 years). The average tumor size was 3.2 cm (1.5-5.6 cm). A median follow-up period of 36 months was obtained to evaluate patient survival and recrudescence.
RESULTS: All 16 procedures were completed laparoscopically without open conversion. The median operation time was 85 minutes (65-125 minutes), with a median estimated blood loss of 50 mL (30-110 mL). The median hospital stay was 5 days (4-7 days). The bladder margins were negative in all cases. However, five cases were confirmed postoperatively with positive lymph nodes. No intraoperative or postoperative complications occurred. Histopathology confirmed mucous urachal adenocarcinoma in 11 cases, mixed carcinoma in 1 case, and papillary adenocarcinoma in 4 cases. After a median follow-up period of 36 months, the 2- and 3-year survival rates were 62.5% (10/16) and 50% (8/16), respectively.
CONCLUSION: Combined laparoscopic extended PC and bilateral extended PLND is a safe and feasible method for treating patients with urachal malignancy.

Entities:  

Mesh:

Year:  2015        PMID: 26531333     DOI: 10.1089/end.2015.0423

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  3 in total

1.  Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score.

Authors:  Liwei Zhao; Ji Sun; Kai Wang; Shengcheng Tai; Runmiao Hua; Yufu Yu; Yi Fan; Jiaguo Huang
Journal:  Cancer Manag Res       Date:  2021-08-16       Impact factor: 3.989

Review 2.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

3.  Urachal Carcinoma: Are Lymphadenectomy and Umbilectomy Necessary?

Authors:  Zhuo Jia; Xiao Chang; Xing Li; Baojun Wang; Xu Zhang
Journal:  Med Sci Monit       Date:  2020-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.